Atorvastatin is the generic name for one of the most widely prescribed medications in the world. Sold under the brand name Lipitor by Pfizer, and in generic form by dozens of manufacturers, atorvastatin is taken daily by tens of millions of Americans to manage high cholesterol and reduce the risk of heart attack and stroke. When a recall is announced for any widely used medication, the concern is understandably widespread — but understanding exactly what a recall means, which products are actually affected, and what steps to take is what separates a well-managed safety response from unnecessary alarm.
Atorvastatin belongs to a class of drugs called statins, which work by blocking an enzyme (HMG-CoA reductase) that the liver uses to produce cholesterol. By reducing LDL ("bad") cholesterol levels and moderately increasing HDL ("good") cholesterol, atorvastatin reduces the buildup of plaque in arteries and lowers the risk of cardiovascular events.
The drug is available in tablet form in doses of 10 mg, 20 mg, 40 mg, and 80 mg. It is typically taken once daily and is generally well tolerated, with the most common side effects being muscle pain (myalgia) and digestive issues.
Pfizer's brand-name Lipitor was the world's best-selling drug for many years before patent expiration in 2011 opened the market to generic competition. Today, generic atorvastatin is manufactured by many companies including Apotex, Teva, Ranbaxy (Sun Pharmaceutical), Mylan, Aurobindo, and others. Each manufacturer independently produces its formulation and is subject to FDA oversight.
Because atorvastatin is produced by multiple manufacturers in large quantities, recalls have occurred for various reasons over the years. These recalls are almost always manufacturer-specific and lot-specific — meaning that a recall by one generic manufacturer does not affect atorvastatin made by a different company, and typically affects only specific production batches even within the recalled manufacturer's products.
Common reasons atorvastatin has been recalled:
Subpotent or superpotent tablets — Tablets that contain more or less of the active ingredient than labeled. This can result in patients receiving inadequate or excessive doses.
Failed dissolution testing — If tablets do not dissolve at the correct rate, the drug may not be absorbed properly by the body. The FDA requires dissolution testing as part of quality standards.
Out-of-specification stability data — If storage testing reveals that a product degrades faster than expected, a recall may be issued to remove product that may no longer be at full potency by its expiration date.
Microbial or particulate contamination — Contamination during manufacturing can affect any medication, including tablets that might seem less susceptible than liquids or injectables.
NDMA contamination concerns — N-nitrosodimethylamine (NDMA) is a probable human carcinogen that became the subject of major drug recalls beginning in 2018, primarily affecting blood pressure medications (valsartan, losartan) and the heartburn drug ranitidine (Zantac). NDMA contamination has also been investigated in statins, though atorvastatin has not been the subject of a major NDMA-driven recall on the scale of the valsartan crisis. The FDA has tested atorvastatin products for NDMA as part of its broader surveillance program.
Labeling and packaging errors — Incorrect labeling, wrong insert documentation, or packaging defects that could cause patient confusion.
To check whether any atorvastatin product is currently under recall, browse current drug recalls. The FDA's MedWatch program also lists all current drug recalls on the FDA website.
The table below covers representative atorvastatin recalls reported to the FDA over recent years. Every recall listed was manufacturer- and lot-specific — no recall removed all atorvastatin from the market. If your manufacturer and lot are not on an active recall notice, your supply is unaffected.
| Year | Manufacturer | Recall Class | Reason | Scope |
|------|-------------|--------------|--------|-------|
| 2023 | Apotex Corp | Class II | Failed dissolution specifications | Consumer-level |
| 2022 | Aurobindo Pharma | Class II | Out-of-specification impurity levels | Retail-level |
| 2021 | Teva Pharmaceuticals | Class II | Subpotent tablets (below labeled strength) | Consumer-level |
| 2020 | Greenstone LLC | Class III | Labeling discrepancy (incorrect lot coding) | Wholesale-level |
| 2019 | Ranbaxy/Sun Pharma | Class II | Stability testing failure (early degradation) | Consumer-level |
| 2018 | Multiple manufacturers | Monitoring | NDMA investigation (no recall issued for atorvastatin) | Surveillance |
Class II recalls — the most common classification for atorvastatin — indicate that the FDA considers the probability of serious harm to be low, but temporary adverse health effects or reduced drug efficacy are possible. Class III recalls, like the 2020 Greenstone labeling issue, rarely require any patient action and are often resolved at the wholesale level before product reaches patients.
For any recall not on this list, or for recalls announced after this article's publication date, check current drug alerts for the most up-to-date information.
Drug recalls in the United States follow a defined process under FDA authority:
Voluntary vs. mandatory recalls. Most drug recalls are initiated voluntarily by the manufacturer after the company identifies a problem through its own quality testing, receives a complaint, or is informed of an issue by the FDA. The FDA has authority to mandate a drug recall if the company refuses to act voluntarily, though this is rarely exercised because most manufacturers cooperate.
Recall classification:
Recall scope — wholesale, retail, or consumer level. Some recalls are conducted at the wholesale level (removing product from distributor warehouses before it reaches pharmacies) and never require action from patients. Others extend to the retail level (pharmacies stop dispensing and return product) or the consumer level (patients are notified to return or discard their medication).
Notification chain. The FDA posts recall notices on its website. Wholesalers notify pharmacies. Pharmacies may contact patients, particularly if the recalled product was dispensed recently and can be identified in dispensing records.
For a broader overview of how drug recalls work and what they mean for patients, see our drug recall guide.
The NDMA contamination crisis that began in 2018 raised public awareness of drug recalls dramatically and is worth understanding even if you take atorvastatin specifically.
NDMA is a chemical compound classified as a probable human carcinogen. It can form as an unintended byproduct in certain manufacturing processes, particularly those involving certain chemical reactions or solvent use. In 2018, the FDA discovered that several manufacturers of valsartan (a blood pressure medication) were producing NDMA as a byproduct of their synthesis process. This triggered a cascade of recalls affecting valsartan, losartan, irbesartan, and eventually ranitidine.
The FDA subsequently tested many other drug classes for NDMA, including statins. Atorvastatin uses a different synthesis pathway than the affected blood pressure drugs, and the FDA's testing did not identify NDMA as a systematic problem in atorvastatin production. However, the agency continues to monitor drug manufacturing and can act quickly if contamination is identified.
The key lesson from the NDMA crisis: drug recalls can affect medications that seem unrelated, because the contamination source is often in manufacturing chemistry rather than in the drug itself. Staying informed through reliable recall tracking resources is more important than assuming any specific drug class is immune.
If you take atorvastatin and want to verify whether your current supply is affected by any recall, follow these steps:
Identify your manufacturer.
Generic drugs from different manufacturers are therapeutically equivalent but are produced in different facilities. Your prescription bottle will indicate the manufacturer name. Common generic atorvastatin manufacturers include Apotex, Teva, Aurobindo, Greenstone, and others.
Find your lot number.
The lot number (also called a lot code or batch number) is printed on the prescription bottle label, usually near the expiration date. It identifies the specific production batch of your medication.
Search for current recalls.
Enter the manufacturer name and "atorvastatin" into the recall search tool or the FDA's drug recall database. Look for any recall notices that match your manufacturer.
Match the lot number.
If a recall exists, compare your lot number against the list of affected lots in the recall notice. Drug recalls typically affect only specific production batches — if your lot number is not on the list, your medication is not subject to that recall.
Contact your pharmacy.
Your pharmacy has access to the same recall information and can quickly check whether the specific lot they dispensed to you is under recall. Many pharmacies proactively contact patients when a dispensed medication is recalled. Your pharmacist is also the right resource for guidance on what to do if your medication is affected.
You can also scan a product barcode using your phone camera to look up a product in our database instantly — useful for over-the-counter supplements and some packaged medications where UPC codes appear on the label.
If you confirm that your medication is subject to an active recall:
Do not stop taking your medication without consulting your doctor. This is critical for cardiovascular medications. Abruptly stopping a statin can have health consequences for people with established heart disease or high cardiovascular risk. The decision to continue, switch, or temporarily hold medication should be made with your prescribing physician.
Contact your pharmacy immediately. Your pharmacy can typically provide a replacement supply of atorvastatin from a non-recalled lot or a different manufacturer, often at no cost to you. They can also process a refund for any recalled product you return.
Call your doctor or cardiologist. Inform your healthcare provider that you have been taking a recalled medication. This is particularly important if you have experienced any unusual symptoms — muscle pain, weakness, or any other side effect — during the period you were taking the recalled product.
Report to MedWatch. If you believe you experienced an adverse effect from a recalled medication, you can report it to the FDA through the MedWatch program at FDA.gov/safety/medwatch.
Do not share or dispose of recalled medication improperly. Return recalled medication to your pharmacy for proper disposal. If a pharmacy return is not available, the FDA provides drug disposal guidance, including drug take-back programs and safe disposal instructions.
Use this checklist if you receive a recall notice or hear about an atorvastatin recall in the news:
If you want to stay ahead of future alerts for any medication in your household, check recalls by brand to monitor specific drug manufacturers.
Many patients feel uncertain about how to discuss a recall with their healthcare provider. A few practical points:
Be direct and specific. Tell your doctor the name of the medication, the manufacturer, and the lot number. If you have the recall notice, bring it or have it available on your phone.
Ask whether you need any monitoring. For most low-severity recalls (Class II or III), no specific medical monitoring is needed. For high-severity recalls involving potential overdose or contamination, your doctor may want to check relevant lab values — including a lipid panel to confirm your cholesterol management remained on track, or CK (creatine kinase) levels if muscle symptoms appeared.
Ask about alternative suppliers. If you are concerned about a particular manufacturer's quality controls, ask whether your prescription can be filled from a different generic manufacturer going forward. All FDA-approved generic atorvastatin must meet the same bioequivalence standards, but your pharmacy may be able to source from a different facility.
Do not make medication changes based on social media or unverified sources. Only act on recall information from official sources — the FDA, your pharmacy, or the current recalls database.
For general guidance on verifying whether any product in your household — food, medication, or consumer goods — is subject to a recall, see how to check if a product is recalled.
Atorvastatin recalls occur periodically and affect specific manufacturers and lot numbers. There is no permanent, ongoing recall of atorvastatin as a drug class. To check whether any atorvastatin is currently under recall, browse current drug recalls or search the FDA drug recall database for current alerts. The status changes frequently as new recalls are initiated and completed.
Not necessarily. Drug recalls span a wide range of severity. A Class I recall involving serious contamination is genuinely urgent. A Class III recall for a minor labeling error poses essentially no health risk. The recall notice will specify the classification and the nature of the concern, which will help you assess the actual risk level of any specific recall.
If your specific lot is recalled, your pharmacy will typically provide product from a different lot or manufacturer automatically. Generic atorvastatin from all FDA-approved manufacturers must meet the same bioequivalence standards, meaning they are therapeutically equivalent. You do not need to insist on any particular manufacturer unless your doctor has a specific clinical reason to prefer one.
The most reliable ways to stay informed are: (1) sign up for FDA drug recall alerts at FDA.gov, (2) set up notifications for drug recalls through the recalls dashboard, and (3) make sure your pharmacy has your current contact information so they can reach you if a medication they dispensed is recalled. Your pharmacy's dispensing records make it possible for them to identify exactly which patients received a recalled lot.
A recall removes a product from the market due to a safety or quality concern. A drug shortage occurs when demand exceeds supply for any reason, including manufacturing problems, ingredient shortages, or distribution disruptions. A recall can contribute to a shortage if it removes a significant portion of available supply from the market, but the two are distinct events with different causes and different implications for patients.
Below is a concise comparison of common recall scenarios for atorvastatin and concrete patient steps you can take immediately. The table summarizes typical causes of recalls, the likely clinical risk, and a short action checklist so you can respond quickly and safely.
| Recall Type | Typical Clinical Risk | What to Do (Patient-level) |
|-------------|-----------------------|----------------------------|
| Contamination (particulates, microbial) | Potential acute harm or infection in rare cases | Quarantine the bottle, stop using only if advised by pharmacist/doctor, return to pharmacy for disposal or replacement. Use `/scan` to log the lot quickly. |
| Potency issues (subpotent/superpotent) | Reduced efficacy or excess dose-related side effects | Continue medication until you consult your prescriber; bring the lot number and manufacturer to your appointment; check `/brands` for alternative manufacturers. |
| Labeling/packaging errors | Low immediate clinical risk but high confusion risk | Retain packaging and follow pharmacy instructions; confirm dosing with pharmacist. |
| Stability/degradation | Possible reduced efficacy over time | Compare expiration and storage history; pharmacy can verify and replace if needed. |
Practical tips: always record the lot number and manufacturer from your bottle before calling the pharmacy; scan the UPC or NDC with RecallTracker's `/scan` tool to check matches against current notices; and ask your clinician whether short-term monitoring (lipid panel or CK) is warranted. Pharmacies can usually replace recalled lots at no cost and will report replacement actions. If you track recalls frequently, consider upgrading to Premium for automated alerts and brand-level monitoring.
Use the barcode scanner in RecallTracker by visiting `/scan` and scanning the UPC or NDC on your bottle; then compare the displayed lot and manufacturer against any active notices. If you prefer manual checks, search `/brands` for your manufacturer and review affected lots, or consult the FDA recall database where {{FDA_COUNT}} recent drug recall notices are listed.
Do not stop taking atorvastatin without speaking to your prescribing clinician — abrupt cessation can raise short-term cardiovascular risk for some patients. Contact your pharmacy to arrange a replacement or switch to a different manufacturer's lot and discuss next steps with your doctor.
Report suspected side effects to the FDA MedWatch program and inform your pharmacy and prescriber; tracking these reports helps regulators and manufacturers respond more quickly. You can view recall and adverse-event trends on our `/statistics` page, which aggregates recall reports including {{RECALL_COUNT}} entries relevant to cardio medications.
Quarantine the product in a secure place and return it to the dispensing pharmacy or a take-back program; do not flush tablets or throw them in household trash unless advised by your local disposal guidance. Use `/scan` to document the lot for your records and to share details with the pharmacist when you return or exchange the medication.
All FDA-approved generic atorvastatin brands meet bioequivalence standards, but manufacturing practices vary; check `/brands` for manufacturer history and lot-level recall frequency before requesting a switch. RecallTracker Premium (`/pricing`) offers proactive brand-level alerts and faster notifications that can reduce exposure time when a manufacturer issues a recall.